MedPath

The effects of magnesium and vitamin D supplement on muscle strength, muscle function, and inflammatory markers in middle-aged women.

Phase 3
Conditions
Sarcopenia, muscle weakness, decrease of muscle strength.
Muscle wasting and atrophy ,not elsewhere classified
Registration Number
IRCT20090822002365N20
Lead Sponsor
personal (expenses will payed by student)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
90
Inclusion Criteria

Voluntary participation
Age from 40 to 55 years old
BMI>=25kg/m2
Having serum vitamin D less than 30 ng/ml

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement of muscle strength in hand and foot. Timepoint: Before the intervention and two months later of intervention. Method of measurement: Dynamometer, Handgrip.
Secondary Outcome Measures
NameTimeMethod
Hs-CRP. Timepoint: Before the intervention and two months later of intervention. Method of measurement: immunoturbidimetry.;TNF-a. Timepoint: Before the intervention and two months later of intervention. Method of measurement: Concentration of TNF-a in serum using ELISA kit.;IL-6. Timepoint: Before the intervention and two months later of intervention. Method of measurement: Concentration of IL-6 in serum using ELISA kit.
© Copyright 2025. All Rights Reserved by MedPath